• (18F)Flutemetamol-PET Aided Classification of Cerebral Amyloid Angiopathy: A Multicenter Study
• Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy
• Alzheimer's Disease Neuropathological Change in Aged Non-Primate Mammals
• Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
• Amyloid-beta Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging
• Amyloid-beta peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome
• An electrostatic cluster guides Abeta40 fibril formation in sporadic and Dutch-type cerebral amyloid angiopathy
• APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in <em>APOE</em> ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics
• Arteriolar degeneration and stiffness in cerebral amyloid angiopathy are linked to beta-amyloid deposition and lysyl oxidase
• Association of Alzheimer's Disease and Other Neuropathologies with Functional Disability in Persons With and Without Dementia
• Associations of Cerebral Small Vessel Disease and Chronic Kidney Disease in Patients With Acute Intracerebral Hemorrhage: A Cross-Sectional Study
• Author Correction: Cognitive profile in cerebral small vessel disease: comparison between cerebral amyloid angiopathy and hypertension-related microangiopathy
• Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study
• Brain MRI in patients with V30M hereditary transthyretin amyloidosis
• Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer's disease
• CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex
• CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex
• Cerebral Amyloid Angiopathy and Nontraumatic Subdural Hemorrhage
• Cerebral Amyloid Angiopathy and Nontraumatic Subdural Hemorrhage-Reply
• Cerebral amyloid angiopathy and the immune system
• Cerebral Amyloid Angiopathy in Patients with Cognitive Impairment -Cerebrospinal Fluid Biomarkers
• Cerebral Amyloid Angiopathy in Patients with Cognitive Impairment: Cerebrospinal Fluid Biomarkers
• Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study
• Cerebral Amyloid Angiopathy: An Undeniable Small Vessel Disease
• Cerebral amyloid-beta-related angiitis and iatrogenic cerebral amyloid angiopathy-related vasculitis: Implications for amyloid-related imaging abnormalities
• Cerebral haemorrhage in the patient with atrial fibrillation: do we employ the direct oral anticoagulants without waiting too long?
• Cerebral Microbleeds Associate with Brain Endothelial Cell Activation-Dysfunction and Blood-Brain Barrier Dysfunction/Disruption with Increased Risk of Hemorrhagic and Ischemic Stroke
• Cerebral microbleeds: Causes, clinical relevance, and imaging approach - A narrative review
• Cerebral tau pathology in cerebral amyloid angiopathy
• Clinical and imaging evolution of cerebral amyloid angiopathy-related inflammation: a long follow-up case
• Clinical and neuroimaging precursors in cerebral amyloid angiopathy: impact of the Boston criteria version 2.0
• Clinical characteristics of cerebral amyloid angiopathy and risk factors of cerebral amyloid angiopathy related intracerebral hemorrhage
• Clinical Presentation and Imaging Findings of Irreversible Cerebral Amyloid Angiopathy-Related Inflammation (CAA-ri): A Case Report and Literature Review
• Correction: Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress
• Correction: Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid angiopathy
• Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRI
• CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysis
• Decreased microvascular claudin-5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage
• Diagnosing Cerebral Amyloid Angiopathy-Related Inflammation
• Diagnostic Accuracy of Posterior/Anterior Periventricular WMH Ratio to Differentiate CAA From Hypertensive Arteriopathy
• Diagnostic yield of computed tomography angiography in patients presenting with spontaneous intracerebral hemorrhage
• Differences in the cerebral amyloid angiopathy proteome in Alzheimer's disease and mild cognitive impairment
• Early-onset Alzheimer's disease with accelerated progression due to cerebral amyloid angiopathy: a case report
• Enhancing Cerebral Amyloid Angiopathy-Related Inflammation Diagnosis With PET Using Pittsburgh Compound B
• Flow in temporally and spatially varying porous media: a model for transport of interstitial fluid in the brain
• GGC repeat expansions in NOTCH2NLC cause uN2CpolyG cerebral amyloid angiopathy
• Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease
• Gustav Oppenheim (1882-1937) and the Discovery of Cerebral Amyloid Angiopathy
• Histological and Memory Alterations in an Innovative Alzheimer's Disease Animal Model by Vanadium Pentoxide Inhalation
• Hypertension control after intracerebral hemorrhage among varying small vessel disease etiologies
• Iatrogenic cerebral amyloid angiopathy after red blood cell transfusion?
• Insufficient evidence for an association between iatrogenic Alzheimer's disease and cadaveric pituitary-derived growth hormone
• Is CAA a perivascular brain clearance disease? A discussion of the evidence to date and outlook for future studies
• Lecanemab and Vascular-Amyloid Deposition in Brains of People With Down Syndrome
• Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains
• Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk
• Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study
• Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats
• Loss of spontaneous vasomotion precedes impaired cerebrovascular reactivity and microbleeds in a mouse model of cerebral amyloid angiopathy
• Magnetic Resonance Imaging-Negative Cerebral Amyloid Angiopathy: Cerebrospinal Fluid Amyloid-beta42 over Amyloid Positron Emission Tomography
• Management of cerebral amyloid angiopathy and atrial fibrillation: We are still far from precision medicine
• Microstructural white matter damage on MRI is associated with disease severity in Dutch-type cerebral amyloid angiopathy
• Non-hemorrhagic imaging markers of cerebral amyloid angiopathy in memory clinic patients
• Novel inflammatory and insulin resistance indices provide a clue in cerebral amyloid angiopathy
• Novel insights into presenilin 1 mutation associated with a distinctive dementia phenotype and cotton wool plaques
• Occult Amyloid-beta-Related Angiitis: Neuroimaging Findings at 1.5T, 3T, and 7T MRI
• One size does not fit all: micro- meso and macrobleeds in cerebral amyloid angiopathy
• Parental Influence on Intracerebral Hemorrhage Onset in Hereditary Dutch-Type Cerebral Amyloid Angiopathy
• Preliminary evidence of high prevalence of cerebral microbleeds in astronauts with spaceflight experience
• Prevalence of Cerebral Amyloid Angiopathy Pathology and Strictly Lobar Microbleeds in East-Asian Versus Western Populations: A Systematic Review and Meta-Analysis
• Prion diseases, always a threat?
• Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid
• Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy
• Quantitative assessment of enlarged perivascular spaces via deep-learning in community-based older adults reveals independent associations with vascular neuropathologies, vascular risk factors and cognition
• Quantitative electroencephalography in cerebral amyloid angiopathy
• Reduced platelet activation and thrombus formation in male transgenic model mice of Alzheimer's disease suggests early sex-specific differences in platelet pathophysiology
• Regional Differences in Microbial Infiltration of Brain Tissue from Alzheimer's Disease Patients and Control Individuals
• Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy
• Serum YKL-40 as a Predictive Biomarker of Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage Recurrence
• Severe cerebral amyloid angiopathy related inflammation (CAA-ri) associated with vaccination: Case report and literature review
• Sex differences in histopathological markers of cerebral amyloid angiopathy and related hemorrhage
• Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy
• Targeted TGF-betaR2 Knockdown in the Retrotrapezoid Nucleus Mitigates Respiratory Dysfunction and Cognitive Decline in a Mouse Model of Cerebral Amyloid Angiopathy with and without Stroke
• Temporal and Spatial Clustering of Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy
• Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease
• The emerging role of the HTRA1 protease in brain microvascular disease
• The hidden link between late-onset seizures and cerebral amyloid angiopathy: A case-control study
• The historical background of hereditary cystatin C amyloid angiopathy: Genealogical, pathological, and clinical manifestations
• The influence of APOE^ε4 on the pTau interactome in sporadic Alzheimer's disease
• The link between Alzheimer's disease and stroke: A detrimental synergism
• The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease
• The presence of circulating human apolipoprotein J reduces the occurrence of cerebral microbleeds in a transgenic mouse model with cerebral amyloid angiopathy
• The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy
• The Role of Aging in Intracerebral Hemorrhage
• The Spectrum of Cerebral Small Vessel Disease: Emerging Pathophysiologic Constructs and Management Strategies
• Three major effects of APOE^ε4 on Aβ immunotherapy induced ARIA
• tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice
• Tumefactive cerebral amyloid angiopathy - related inflammation
• Vascular Heparan Sulfate and Amyloid-beta in Alzheimer's Disease Patients
• Vasculitis in the Central Nervous System: Etiology, Characteristics, and Outcomes in a Large Single-Center Cohort